Condition 1: Anxiety. Condition 2: stress. Anxiety disorder due to known physiological condition Acute stress reaction
Conditions
Interventions
Intervention 1: Control group: Participants do not receive intervention during the 12 weeks. Intervention 2: Intervention group: Participants receive 2 30-minute neurofeedback training session (The EE
Montreal, Quebec) transmite the signal to the computer. The EEG serves both as a means of recording and as a source for feedback, with a sampling rate of 256 Hz samples/second, and the data was redire
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: Achieving a score above 18 on the stress scale of the Stress, Anxiety and Depression Questionnaire (DASS-21) Age range between 18 to 25 years old
Exclusion criteria
Exclusion criteria: Presence or history of severe psychiatric disorders (including periods of severe depression, anxiety disorders, substance use disorders) Smoking and psychedelic pills Using psychiatric drugs Epilepsy Various cardiovascular and respiratory disorders and blood pressure Aspirin use and acetaminophen over the past 48 hours history of cancer diabetes hypothyroidism or hyperthyroidism Addison disease Cushing's syndrome hypertension Use of corticosteroids and steroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety symptoms. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;Stress. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;Cortisol. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;a amylase. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaba Hasanvandi
Bagheiat-allah University of Medical Sciences
Outcome results
None listed